About Bioline  All Journals  Testimonials  Membership  News

European Journal of General Medicine
Medical Investigations Society
ISSN: 1304-3897
Vol. 4, Num. 4, 2007, pp. 176-179

European Journal of General Medicine, Vol. 5, No. 4, 2008, pp. 176-179

Investigation Of Anti-inflammatory Activity Of Bergamot Oil

Mehmet Karaca1, Hanefi Özbek2, Aydın Him3, Mehmet Tütüncü1, Hasan Altan Akkan1, Veysel Kaplanoğlu2

Yüzüncü Yıl University, Faculty of Veterinary Medicine, Department of Internal Medicine1, Medical Faculty, Departments of Pharmacology2 and Physiology3, Van, Turkey
Correspondence: Hanefi Özbek , MD , PhD. Yüzüncü Yıl Üniversitesi, Tıp Fakültesi Farmakoloji AD 65300 Van, Turkey Fax: 904322168352 E-mail:

Code Number: gm07041

Aim: Essential oil of Bergamot (BO) was investigated for anti-inflammatory activity using carrageenan-induced rat paw oedema test.
Methods: For the anti-inflammatory activity measurement six different groups were established and BO was administered in three different doses: 0.025, 0.05 and 0.10 mL/kg. Indomethacin was used as a reference agent.
Results: It was found that reduction in the inflammation was 95.70% with indomethacin, 27.56% with 0.025 mL/kg BO, 30.77% with 0.05 mL/kg BO and 63.39% with 0.10 mL/kg BO. Indomethacin showed the strongest anti-inflammatory activity among the drugs used. The strongest anti-inflammatory activity of BO was seen with 0.10 mL/kg dosage. Median effective dose (ED50) value of BO was found to be 0.079 mL/kg.
Conclusion: The results showed that BO posseses promising anti-inflammatory effect.

Key words: Citrus aurantium subsp. bergamia, Bergamot oil, anti-inflammatory activity, carrageenan-oedema.


Citrus aurantium subsp. bergamia is a member of the Rutaceae. In Turkish folk medicine, Citrus species have several uses such as for their appetizing, diaphoretic, antiseptic, analgesic and anti-inflammatory effects (1). The Bergamot oil (BO) is a roughly pear-shaped citrus fruit. The fruit is produced in Italy, East Africa, Ivory Coast, Argentina, Brazil, Turkey and some other Mediterranean countries. The fruit is sour, and its aromatic peel is used to produce an essential oil that is used in Earl Grey tea, in perfumery, in candy-making (2). It is known empirically that inhalation of essential oils causes physiological and psychological changes in humans (3). Graham et al reported that aromatherapy during radiotherapy with bergamot oil and some other kinds of plant oil was not beneficial (4). The BO oil has been linked to several negative side-effects such as photosensitivity (5-7). The essential oil of BO is extracted from the peel of the fruit by a cold-pressing procedure or steam distillation. It consists of a volatile fraction, whose main components are, in approximate percentages, limonene (40%), linalool (8%), linalyl acetate (28%), bergapten, citropten, bergamottin, gamma-terpinen, alpha-pinene, beta-pinene, and a non-volatile fraction (4–7%) formed essentially by coumarins and psoralens (2,8).

It has been reported that bergamot oil exhibited antifungal activity against some dermatophytes and antibacterial activity against Campylobacter jejuni, Escherichia coli O157, Listeria monocytogenes, Bacillus cereus and Staphylococcus aureus (9,10).

Some of the components of BO, limonene, linalool, linalyl acetate and alpha-pinene, were shown to have anti-inflammatory effects (11-13). Therefore it is likely that BO has anti-inflammatory activity.

In this study, essential oil extract of Bergamot oil was investigated for its antiinflammatory activity using carrageenaninduced rat paw oedema test (14).


Preparation of BO essential oil extract

Citrus aurantium L. var bergamia was collected in February, 2006 near Antalya (Turkey) and voucher specimens are kept in Yuzuncu Yil University, Faculty of Medicine (Specimen Nr: B-14).

Table 1. Effects of intraperitoneal treatment with the essential oil extract of Bergamot orange on carrageenan-induced hind paw oedema in rats (n:6)

Paw oedema at 3 h Percentage inhibition
Groups (mL ± SEM)* (%)
Control-I (ISS**) 1.043±0.127 -
Control-II (etil alcohol) 0.988±0.113 -
Indomethacin (3 mg/kg) 0.042±0.023 ab 95.70
Bergamot orange (0.025 mL/kg) 0.753±0.072 abc 27.56
Bergamot orange (0.050 mL/kg) 0.720±0.073 abc 30.77
Bergamot orange (0.10 mL/kg) 0.381±0.087 abcde 63.39

*SEM: Standard error of mean.
**ISS: Isotonic saline solution (0.9% NaCl).
a: p<0.05 with respect to control-I group.
b: p<0.05 with respect to control-II group.
c: p<0.05 with respect to indomethacin group.
d: p<0.05 with respect to Bergamot orange (0.025 mL/kg) group.
e: p<0.05 with respect to Bergamot orange (0.05 mL/kg) group

The plant samples were kept at room temperature until they were processed. The fruits were peeled and the fresh pericarp of the fruit was sliced into small pieces and boiled in Clevenger apparatus (Ildam, TURKEY) to obtain essential oil of the Citrus aurantium var. bergamia (BO). BO was kept in test tubes and the yield was determined as 0.7%.

Drugs and chemicals

The following drugs were used; Lambda-Carrageenan and indomethacin (Sigma, Steinheim, Germany). Indomethacin was dissolved in ethyl alcohol (96 %).


Male and female Sprague-Dawley rats (180-220 g) were used in these experiments. The animals were housed in standard cages (48 cm x 35 cm x 22 cm) with food and water ad libitum, at room temperature (20 ± 2 0C) with artificial light from 7.00 am to

7.00 pm. The animals kept under controlled environment following the standard operating procedures of the animal house facility of the Faculty of Medicine, and provided with pelleted food Animal Feed Factory, Van-Turkey). The protocol for the study was approved of Yüzüncü Yıl University, Faculty of Medicine Animal Breeding and Research. Prior to administration of the drugs, the rats were fasted for 12 h with free access to tap water.

Carrageenan-induced rat paw oedema

Thirty-six rats of either sex were divided into six groups of six animals each. Group I, which served as control-I, received 0.2 mL isotonic saline solution (ISS), Group II, which served as control-II, received 0.2 mL ethanol. Group III received 3 mg/kg,indomethacin (14), group IV received 0.025 mL/kg BO,. Group V received 0.05 mL/kg BO. Group VI received 0.100 mL/kg BO. All agents were injected intraperitoneally.

The inhibitory activity of BO on carrageenan-induced rat-paw oedema was determined according to the method of Winter et al, with slight modification (15). The drugs were administered 1 h before the injection of 0.05 mL of carrageenan (1%) into the subcutaneous tissue of right hind paw. Since the hydration state of the animals can modify the intensity of swelling, the rats were fasted 12 h before the experiment with water ad libitum. The degree of oedema was measured 30 minutes before and 3 h after the injection of carrageenan. The difference between the volume of the paw before and after the injection of the oedema provoking agent indicated the severity of oedema. Volumes of right hind paw of the animals were measured with a plethysmometer (model 7140, Ugo Basile, Italy).

The percentage inhibition of the inflammatory reaction was determined for each animal by comparing with controls and calculated by the formula (16):

I % = [(1-(dt/dc)] x 100

where dt is the difference in paw volume in the drug-treated group and dc the difference in paw volume in the control group.

Statistical analysis

All data were represented as mean ± standard error of mean (SEM) or as percentages. The analysis of variance (ANOVA) was used for the statistical analysis of data. LSD test (Least significant difference test) was used for determining significance. Results with p<0.05 were considered as statistically significant.


Table 1 shows the results on antioedematous effect of intraperitoneally administered Bergamot oil on carrageenan paw oedema in rats. At doses of 0.025, 0.05 and 0.100 mL/kg BO caused a significant reduction in paw oedema (27.56%, 30.77% and 63.93%, respectively). In this model, indomethacin, a commonly used anti-inflammatory drug, produced a significant inhibition by 95.70%. As seen in Table 1, all doses of BO showed anti-inflamatory activity higher than that of the control groups, but it was not as strong as indomethacin. Anti-inflammatory activity of 0.100 mL/kg BO was stronger than those of 0.025 and 0.05 mL/kg BO.


Bergamot oil (Citrus aurantium subsp. bergamia) essential oil has been used for its diaphoretic, appetizing, antiseptic, analgesic and anti-inflammatory effects (1).

Anti-inflammatory effect of Bergamot oil shown in this study confirms its use as an anti-inflammatory agent in traditional medicine. Median effective dose (ED50) value of BO was found to be 0.079 mL/kg. It was reported that main components of the volatile fraction of BO essential oil are limonene, linalool, linalyl acetate, bergapten, citropten, bergamottin, gamma-terpinen, alpha-pinene and beta-pinene (2,8). Antiinflammatory effect of BO essential oil could be due to one or several of these components. Linalool, linalyl acetate, limonene and alpha-pinene were shown to have strong antiinflammatory effects (11-13), which supports the results obtained in the current study. More studies are needed to show the mechanisms of the anti-inflammatory effects of these agents. Bergapten, citropten, bergamottin, gammaterpinen and beta-pinene, which are also found in BO essential oil, should be further studied for their anti-inflammatory effects.

The results of the present study showed that BO had anti-inflammatory effect and provided support to the traditional usage of BO in inflammation.


  1. Gürkan E, Öndersev DV, Ulusoylu M, Göztaş Z, Dinçşahin N. Fitoterapi. Istanbul-Turkey, Marmara University Press , 2003, pp: 28, 38, 74.
  2. Cum G, Kunkar C Kunkar A. Supercritical CO2 extraction of Citrus Bergamia Risso oil. Proceedings of the 9th Smposium on Plant Originated Crude Drugs, 16-9 May 1991, Eskişehir, Turkey
  3. Tisserand R. The Art of Aromatherapy. Chapter Ed: C.W. Daniel, Essex, 1977.
  4. Graham PH, Browne L, Cox H, Graham J. Inhalation aromatherapy during radiotherapy: results of a placebocontrolled double-blind randomized trial. J Clin Oncol 2003;21(12):2372-6
  5. Zacher KD, Ippen H. Contact dermatitis caused by bergamot oil. Derm Beruf Umwelt 1984;32(3):95-7
  6. Kaddu S, Kerl H, Wolf P. Accidental bullous phototoxic reactions to bergamot aromatherapy oil. J Am Acad Dermatol 2001;45(3):458-61
  7. Weisenseel P, Woitalla S. Toxic mustard plaster dermatitis and phototoxic dermatitis after application of bergamot oil. MMW Fortschr Med 2005;147(5152):53-5
  8. Romano L, Battaglia F, Masucci L, Sanguinetti M, Posteraro B, Plotti G, Zanetti S, Fadda G. In vitro activity of bergamot natural essence and furocoumarin-free and distilled extracts, and their associations with boric acid, against clinical yeast isolates. J Antimic Chem 2005;55(1):110-4
  9. Sanguinetti M, Posteraro B, Romano L, Battaglia F, Lopizzo T, De Carolis E, Fadda G. In vitro activity of Citrus bergamia (bergamot) oil against clinical isolates of dermatophytes. J Antimicrob Chemother 2006 (In press)
  10. Fisher K, Phillips CA. The effect of lemon, orange and bergamot essential oils and their components on the survival of Campylobacter jejuni, Escherichia coli O157, Listeria monocytogenes, Bacillus cereus and Staphylococcus aureus in vitro and in food systems. J Appl Microbiol. 2006;101(6):1232-40
  11. Peana AT, D’Aquila PS, Panin F, Serra G, Pippia P, Moretti MD. Antiinflammatory activity of linalool and linalyl acetate constituents of essential oils. Phytomedicine 2002;9(8):721-6
  12. Özbek H, Sever B. Investigation of lethal doses and anti-inflammatory effect of Alpha-pinene on mice and rats. Turkish Pharmacological Society 18th National Pharmacology Congress, September 2005, Izmir-Turkey, P-118
  13. Sever B, Özbek H. Investigation of lethal doses and anti-inflammatory effect of Alpha-pinene on mice and rats. Turkish Pharmacological Society 18th National Pharmacology Congress, September 2005, Izmir-Turkey, P-72
  14. Winter CA, Risley EA, Nuss GW. Carragenin-induced edema in hind paw of the rats as an assay for antiinflammatory drugs. Proc Soc Exp Biol Med 1962;111: 544-7
  15. Rimbau V, Cerdan C, Vila R. Antiinflammatory activity of some extracts from plants used in the traditional medicine of North-African countries (II). Phytother Res 1999;13:128-32
  16. Kouadio F, Kanko C, Juge M, Grimaud N, Jean A, Guessan YTN, Petit JY. Analgesic and antiinflammatory activities of an extract from Parkia biglobosa used in traditional medicine in the Ivory Coast. Phytother Res 2000;14:635-7

Copyright 2007 - European Journal of General Medicine

The following images related to this document are available:

Photo images

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil